David Erlanger
Overview
Explore the profile of David Erlanger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
373
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Erlanger D, Assous M, Wiener-Well Y, Yinnon A, Ben-Chetrit E
J Microbiol Immunol Infect
. 2017 Sep;
52(3):443-448.
PMID: 28919283
Background: There are few studies of Morganella bacteremia. We evaluated risk factors and outcome of patients with Morganella bacteremia. Methods: Medical records of patients with Morganella bacteremia were reviewed (1997-2014)....
2.
Benedict R, Smerbeck A, Parikh R, Rodgers J, Cadavid D, Erlanger D
Mult Scler
. 2012 Jan;
18(9):1320-5.
PMID: 22277740
Background: Cognitive impairment is common in multiple sclerosis (MS), but is seldom assessed in clinical trials investigating the effects of disease-modifying therapies. The Symbol Digit Modalities Test (SDMT) is a...
3.
Sumowski J, Chiaravalloti N, Erlanger D, Kaushik T, Benedict R, DeLuca J
Mult Scler
. 2011 May;
17(9):1141-5.
PMID: 21561956
Background: Memory impairment is prevalent in multiple sclerosis (MS), but no drugs are approved to treat these memory problems. Objective: The objective of the study was to examine the effect...
4.
Morrow S, Kaushik T, Zarevics P, Erlanger D, Bear M, Munschauer F, et al.
J Neurol
. 2009 Mar;
256(7):1095-102.
PMID: 19263186
Defects in processing speed and memory are common in multiple sclerosis (MS) patients. In other populations, amphetamines have been shown to enhance cognition, but their use is limited by adverse...
5.
Medalia A, Lim R, Erlanger D
Comput Methods Programs Biomed
. 2005 Sep;
80(2):93-102.
PMID: 16140419
Traditional neuropsychological tests have been essential in understanding the nature and magnitude of the cognitive deficits associated with schizophrenia. However, current health care practices demand a more cost-effective and time-efficient...
6.
Broshek D, Kaushik T, Freeman J, Erlanger D, Webbe F, Barth J
J Neurosurg
. 2005 Jun;
102(5):856-63.
PMID: 15926710
Object: Females comprise an increasing percentage of the athlete population across all age groups, and analysis of recent literature reveals that they sustain more concussions in collegiate sports. Results of...
7.
Erlanger D, Feldman D, Kutner K, Kaushik T, Kroger H, Festa J, et al.
Arch Clin Neuropsychol
. 2003 Nov;
18(3):293-316.
PMID: 14591461
The Concussion Resolution Index (CRI) is an online assessment tool designed to track resolution of symptoms following sports-related concussion. The CRI is composed of six subtests measuring reaction time, visual...
8.
Erlanger D, Saliba E, Barth J, Almquist J, Webright W, Freeman J
J Athl Train
. 2003 Aug;
36(3):280-287.
PMID: 12937497
OBJECTIVE: A new Web-based neuropsychological test was field tested to determine usefulness in detecting and monitoring resolution of symptoms after sport-related concussions and in providing objective information for return-to-play decisions....
9.
Erlanger D, Kaushik T, Cantu R, Barth J, Broshek D, Freeman J, et al.
J Neurosurg
. 2003 Mar;
98(3):477-84.
PMID: 12650417
Object: Current grading systems of concussion and return-to-play guidelines have little empirical support. The authors therefore examined the relationships of the characteristics and symptoms of concussion and the history of...